Abstract
Background Adverse drug reactions (ADRs) are undesirable effects to drugs at doses normally used in the clinical setting for diagnosis, treatment or prophylaxis of diseases. Spontaneous ADR reporting is currently considered as a critical part of ADRs detection. Objective The study aims to assess the knowledge, attitude, and practice of healthcare providers towards adverse drug reaction reporting in public and private settings within the Baghdad area. Method We follow a quantitative cross-sectional study design, using a self-administered questionnaire to collect data from the healthcare providers regarding their reporting practice. Main outcome The outcome measures include the experiences of reporting of adverse drug reactions and the available systems, in addition to the expected benefits to clinical practice. Results Among 485 respondents, 114 were able to differentiate ADRs from side effects. About half of them (47.6%) recognized the availability of reporting systems and 43.3% knew how to report adverse drug reactions. 43.7% of the respondents mentioned that ADRs should be reported only when they are life-threatening. Among the 188 respondents who encountered ADRs, 145 reported the events to the accessible local authority. Conclusion The healthcare providers working in Baghdad healthcare institutions have a good attitude toward ADR reporting. There is a relatively below-standard reporting culture of the encountered adverse reactions. The inadequate knowledge about adverse reactions and the unavailability of reporting forms played a major role in discouraging healthcare professionals to detect and report ADRs.
Similar content being viewed by others
Explore related subjects
Discover the latest articles, news and stories from top researchers in related subjects.References
Gautron S, Wentzell J, Kanji S, Nguyen T, Kobewka DM, MacDonald E. Characterization of serious adverse drug reactions in the hospital to determine potential implications of mandatory reporting. Can J Hosp Pharm. 2018;71(5):316–23.
Li R, Curtain C, Bereznicki L, Zaidi STR. Community pharmacists’ knowledge and perspectives of reporting adverse drug reactions in Australia: a cross-sectional survey. Int J Clin Pharm. 2018;40(4):878–89.
Ahmad A, Patel I, Balkrishnan R, Mohanta G, Manna P. An evaluation of knowledge, attitude and practice of Indian pharmacists towards adverse drug reaction reporting: a pilot study. Perspect Clin Res. 2013;4(4):204–410.
Mascolo A, Scavone C, Sessa M, et al. Can causality assessment fulfill the new European definition of adverse drug reaction? A review of methods used in spontaneous reporting. Pharmacol Res. 2017;123:122–9.
Pirmohamad M, James S, Meakin S, et al. Adverse drug reactions as cause of admission to hospital: prospective analysis of 18,820 patients. Br Med J. 2004;329:15–9.
Pirmohamed M, Breckenridge A, Kitteringham N, Park B. Fortnightly review. Adverse drug reactions. Br Med J. 1998;316:1295–8.
Davies EC, Green CF, Taylor S, Williamson PR, Mottram DR, Pirmohamed M. Adverse drug reactions in hospital in-patients: a prospective analysis of 3695 patient-episodes. PLoS ONE. 2009;4:e4439.
Saha L. Role of pharmacovigilance in drug development. Enliven Pharmacovigil Drug Saf. 2014;1(1):9–10.
Ponmari SJ, Sivaraman M, Aruna T, Subashree V. Knowledge and awareness of pharmacovigilance among various medical fraternities. Asian J Pharmacol Toxicol. 2015;03(10):45–8.
Williams D, Feely J. Underreporting of adverse drug reactions: attitudes of Irish doctors. Ir J Med Sci. 1999;168:257–61.
Black N. Why we need observational studies to evaluate the effectiveness of health care. Br Med J. 2011;312:1215–8.
Aagaard L, Soendergaard B, Stenver DI, Hansen EH. Knowledge creation about ADRs-turning the perspective from the rear mirror to the projector. Br J Clin Pharmacol. 2008;65:364–76.
Tyrer S, Heyman B. Sampling in epidemiological research: issues, hazards, and pitfalls. BJPsych Bull. 2016;40(2):57–60.
Kamtane RA, Jayawardhani V. Knowledge, attitude and perception of physicians towards adverse drug reaction (ADR) reporting: a pharmacoepidemiological study. Asian J Pharm Clin Res. 2012;5(3):210–4.
Gupta SK, Nayak RP, Shivaranjani R, Vidyarthi SK. A questionnaire study on the knowledge, attitude, and the practice of pharmacovigilance among the healthcare professionals in a teaching hospital in South India. Perspect Clin Res. 2015;6(1):45.
Okada K. Bayesian meta-analysis of Cronbach’s coefficient alpha to evaluate informative hypotheses. Res Synth Methods. 2015;6(4):333–46.
Opadeyi AO, Fourrier-Réglat A, Isah AO. An educational intervention to improve the knowledge, attitude, and practice of healthcare professionals regarding pharmacovigilance in South-South Nigeria. Ther Adv Drug Saf. 2019;10:2042098618816279.
Wiffen P, Gill M, Edwards J, Moore A. Adverse drug reactions in hospital patients: a systematic review of the prospective and retrospective studies. Bandolier Extra. 2002;101(4):1–15.
Mukattash TL, Alwadi MW, Abu-Farha RK, Jarab AS, Al-Zubiedi SA, Alwedyan T. Knowledge, attitudes, and practices of pharmacovigilance and ADRs spontaneous reporting among pediatricians and pediatric residents in Jordan. Curr Clin Pharmacol. 2018;13(1):45–54.
AlShammari TM, Almoslem MJ. Knowledge, attitudes and practices of healthcare professionals in hospitals towards the reporting of adverse drug reactions in Saudi Arabia: a multi-center cross-sectional study. Saudi Pharm J. 2018;26(7):925–31.
Ernst FR, Grizzle AJ. Drug-related morbidity and mortality: updating the cost of illness model. J Am Pharm Assoc (Wash). 2001;41(2):192–9.
Angamo MT, Wabe NT. Knowledge, attitude and practice of adverse drug reaction reporting among health professionals in South West Ethiopia. TAF Prev Med Bull. 2012;11(4):397–406.
Abatemarco D, Perera S, Bao SH, et al. Training augmented intelligent capabilities for pharmacovigilance: applying deep-learning approaches to individual case safety report processing. Pharmaceut Med. 2018;32(6):391–401.
Su C, Ji H, Su Y. Hospital pharmacists’ knowledge and opinions regarding adverse drug reaction reporting in Northern China. Pharmacoepidemiol Drug Saf. 2010;19(3):217–22.
Kazeam A, Jacob O. Perceptions of doctors to adverse drug reaction reporting in a teaching Hospital in Lagos, Nigeria. BMC Clin Pharmacol. 2009;9:14.
Herdeiro MT, Figueiras A, Polonia J, Gestal-Otero JJ. Influence of pharmacists’ attitudes on adverse drug reaction reporting: a case-control study in Portugal. Drug Saf. 2006;29(4):331–40.
Sabblah GT, Akweongo P, Darko D, Dodoo AN, Sulley AM. Adverse drug reaction reporting by doctors in a developing country: a case study from Ghana. Ghana Med J. 2014;48(4):189–93.
Alshammari TM, Alamri KK, Ghawa YA, Alohali NF, Abualkol SA, Aljadhey HS. Knowledge and attitude of health-care professionals in hospitals towards pharmacovigilance in Saudi Arabia. Int J Clin Pharm. 2015;37(6):1104–10.
Toklu HZ, Uysal MK. Knowledge and attitude of Turkish community pharmacists towards pharmacovigilance in the Kadikoy district of Istanbul. Pharm World Sci. 2008;30(5):556–62.
Fincham JE. Response rates and responsiveness for surveys, standards, and the Journal. Am J Pharm Educ. 2008;72(2):43.
Acknowledgements
The authors thank the Faculty of Pharmacy, Al-Rafidain University College for support, and gratefully thank all healthcare providers who participated in this study.
Funding
No funding was obtained for the current study.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflicts of interest
The authors declared no conflicts of interest in this work.
Data sharing statement
The datasets analyzed during the current study will be available from the corresponding author on a reasonable request.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Hussain, S.A., Abbas, A.N., Habeeb, SZ.A. et al. Healthcare personnel’s experience of reporting adverse drug reactions in Baghdad city: cross-sectional study. Int J Clin Pharm 41, 1307–1313 (2019). https://doi.org/10.1007/s11096-019-00867-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11096-019-00867-7